VRTX:NGS-Vertex Pharmaceuticals Incorporated (USD)

EQUITY | Biotechnology | Nasdaq Global Select

Last Closing

USD 442

Change

-3.87 (-0.87)%

Market Cap

USD 21.38B

Volume

1.04M

Analyst Target

USD 306.43
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
REGN Regeneron Pharmaceuticals Inc

+9.97 (+0.97%)

USD 110.51B
MRNA Moderna Inc

-5.20 (-3.58%)

USD 57.87B
BNTX BioNTech SE

-3.92 (-4.08%)

USD 24.18B
ARGX argenx NV ADR

-1.34 (-0.35%)

USD 23.09B
ALNY Alnylam Pharmaceuticals Inc

+0.34 (+0.21%)

USD 20.25B
GMAB Genmab AS

-0.22 (-0.83%)

USD 18.17B
BGNE BeiGene Ltd

-3.80 (-2.28%)

USD 17.74B
RPRX Royalty Pharma Plc

-0.28 (-1.03%)

USD 16.18B
BMRN Biomarin Pharmaceutical Inc

-0.73 (-0.87%)

USD 15.32B
INCY Incyte Corporation

-0.58 (-0.93%)

USD 13.30B

ETFs Containing VRTX

DCCHAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

+0.01 (+-0.79%)

USD 0.07B
DCUSAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

N/A

USD 0.07B
DCEUAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

N/A

USD 0.02B
DCGBAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

N/A

USD 2.05M
CURE:XETRA VanEck Genomics and Healt.. 9.16 % 0.00 %

-0.25 (-0.79%)

USD 6.79M
CURG:LSE VanEck Genomics and Healt.. 8.84 % 0.00 %

-0.12 (-0.79%)

USD 6.79M
BTEC:SW iShares Nasdaq US Biotech.. 8.65 % 0.00 %

-0.03 (-0.79%)

USD 0.47B
MSGR 8.22 % 0.00 %

N/A

N/A
UBIO 6.52 % 0.95 %

N/A

N/A
LIFE-U:CA Evolve Global Healthcare .. 5.00 % 0.00 %

N/A

N/A
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.79 % 0.00 %

-0.16 (-0.79%)

USD 3.46M
XGES:LSE Xtrackers MSCI Genomic He.. 4.78 % 0.00 %

-0.09 (-0.79%)

USD 3.46M
ZWHC:CA BMO Covered Call Health C.. 4.63 % 0.00 %

N/A

CAD 0.01B
XNNV:XETRA Xtrackers MSCI Innovation.. 4.61 % 0.00 %

+0.15 (+-0.79%)

USD 7.78M
XNNS:LSE Xtrackers MSCI Innovation.. 4.54 % 0.00 %

+0.16 (+-0.79%)

USD 7.78M
XNNV:LSE Xtrackers MSCI Innovation.. 4.54 % 0.00 %

-0.04 (-0.79%)

USD 7.78M
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.30 % 0.00 %

+0.27 (+-0.79%)

USD 0.15B
FTXH First Trust Nasdaq Pharma.. 4.21 % 0.60 %

-0.06 (-0.79%)

USD 0.02B
XDGI:XETRA Xtrackers MSCI Global SDG.. 3.63 % 0.00 %

+0.01 (+-0.79%)

USD 0.01B
HEAL:CA 3.39 % 0.00 %

N/A

N/A
CACG ClearBridge All Cap Growt.. 3.19 % 0.53 %

+0.07 (+-0.79%)

USD 0.12B
CDNA:CA CI Bio-Revolution ETF 3.09 % 0.00 %

N/A

CAD 5.88M
UPWD 2.43 % 0.00 %

N/A

N/A
QQXT First Trust NASDAQ-100 Ex.. 1.98 % 0.60 %

-0.22 (-0.79%)

USD 0.13B
XMLH:F Legal & General Ucits Etf.. 1.93 % 0.00 %

-0.06 (-0.79%)

USD 0.07B
DOCT:SW L&G Healthcare Breakthrou.. 1.93 % 0.00 %

-0.15 (-0.79%)

USD 0.07B
XLVE:CA Mulvihill U.S. Health Car.. 1.69 % 0.00 %

N/A

CAD 7.08M
MVEA:SW iShares Edge MSCI USA Min.. 1.56 % 0.00 %

-0.01 (-0.79%)

USD 0.30B
ESMV iShares ESG MSCI USA Min .. 1.56 % 0.00 %

+0.01 (+-0.79%)

USD 0.01B
MVEW:LSE iShares Edge MSCI World M.. 1.43 % 0.00 %

+0.03 (+-0.79%)

USD 0.54B
QQEW First Trust NASDAQ-100 Eq.. 1.18 % 0.60 %

+0.07 (+-0.79%)

USD 2.06B
THNZ:XETRA L&G Global Thematic ESG E.. 1.00 % 0.00 %

-0.06 (-0.79%)

USD 4.34M
EVO:CA Evovest Global Equity ETF 0.95 % 0.00 %

-0.25 (-0.79%)

CAD 0.02B
LABU Direxion Daily S&P Biotec.. 0.71 % 1.14 %

-8.17 (-0.79%)

USD 1.10B
SMRU:PA Amundi Index Solutions - .. 0.71 % 0.00 %

-2.76 (-0.79%)

USD 3.28M
BBH VanEck Biotech ETF 0.00 % 0.35 %

-0.62 (-0.79%)

USD 0.44B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

-0.89 (-0.79%)

USD 0.09B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

+0.23 (+-0.79%)

USD 3.30M
DEF 0.00 % 0.59 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-0.88 (-0.79%)

USD 7.34B
LABD Direxion Daily S&P Biotec.. 0.00 % 1.00 %

+0.49 (+-0.79%)

USD 0.11B
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

-0.54 (-0.79%)

USD 0.26B
SPGP Invesco S&P 500 GARP ETF 0.00 % 0.36 %

-0.70 (-0.79%)

USD 4.83B
HTEC Robo Global® Healthcare .. 0.00 % 0.00 %

-0.29 (-0.79%)

USD 0.06B
ZPW-U:CA BMO US Put Write ETF 0.00 % 0.00 %

N/A

N/A
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.06 (-0.79%)

USD 0.47B
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.01 (-0.79%)

USD 0.47B
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.06 (-0.79%)

USD 0.04B
VLQ:CA 0.00 % 0.40 %

N/A

N/A
ZBIO 0.00 % 0.95 %

N/A

N/A
SMRG:LSE 0.00 % 0.00 %

N/A

N/A
SMRU:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

-2.50 (-0.79%)

USD 3.32M
VMOM:LSE 0.00 % 0.00 %

N/A

N/A
SMRT:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.03B
2B70:F iShares NASDAQ US Biotech.. 0.00 % 0.00 %

-0.01 (-0.79%)

USD 0.52B
SM8T:F Amundi Index Solutions - .. 0.00 % 0.00 %

-0.40 (-0.79%)

N/A
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.02 (-0.79%)

USD 0.52B
SM8T:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+1.20 (+-0.79%)

USD 0.04B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
MVEA:XETRA iShares Edge MSCI USA Min.. 0.00 % 0.00 %

+0.05 (+-0.79%)

USD 0.32B
FLXU:LSE Franklin LibertyQ U.S. Eq.. 0.00 % 0.00 %

+0.17 (+-0.79%)

USD 0.18B
JEPI JPMorgan Equity Premium I.. 0.00 % 0.00 %

-0.11 (-0.79%)

USD 33.58B
NVQ 0.00 % 0.00 %

N/A

N/A
FRUE:LSE Franklin LibertyQ U.S. Eq.. 0.00 % 0.00 %

-0.12 (-0.79%)

USD 0.18B
FBT:LSE First Trust Global Funds .. 0.00 % 0.00 %

-9.70 (-0.79%)

USD 5.63M
FBTU:LSE First Trust Global Funds .. 0.00 % 0.00 %

-0.19 (-0.79%)

USD 5.63M
SXQG 6 Meridian Quality Growth.. 0.00 % 0.00 %

+0.16 (+-0.79%)

USD 0.04B
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

-0.18 (-0.79%)

USD 0.03B
KONG Formidable Fortress ETF 0.00 % 0.00 %

-0.12 (-0.79%)

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.63% 64% D 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.63% 64% D 69% C-
Trailing 12 Months  
Capital Gain 32.53% 79% B- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.53% 79% B- 81% B-
Trailing 5 Years  
Capital Gain 155.48% 88% B+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 155.48% 88% B+ 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 19.64% 73% C 79% B-
Dividend Return 19.64% 73% C 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 27.81% 89% A- 65% D
Risk Adjusted Return 70.63% 98% N/A 90% A-
Market Capitalization 21.38B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Biotechnology) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 27.47 21% 34%
Price/Book Ratio 5.83 24% 19%
Price / Cash Flow Ratio 30.84 3% 9%
Price/Free Cash Flow Ratio 20.00 2% 12%
Management Effectiveness  
Return on Equity 24.38% 98% 92%
Return on Invested Capital 18.99% 90% 87%
Return on Assets 12.82% 99% 97%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.